Al Hammadi’s Pharma Serve wins SAR 347 mln contract
30/04/2018
Argaam

Saudi Arabia’s National Unified Procurement Co. (NUPCO) on Sunday awarded Pharma Serve, a subsidiary of Al Hammadi Company for Development and Investment, a two-year contract worth SAR 347 million to provide vaccines to government health authorities.
Pharma Serve is a wholly-owned subsidiary of Medical Support Services Company, which in turn is a subsidiary of Al Hammadi.
The deal’s financial impact is expected to show on Al Hammadi’s Q3 resultsthe Saudi healthcare firm said in a statement on Tadawul.
Market Indices
TASI
10,878.46
13.89
0.13 %
Quotes
ALHAMMADI
24.15
(0.28)
(1.15%)
Call Request
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}